Consumer-Centric Solutions Drive Growth
From wearables to mobile applications, Digital Health and Health Tech companies are improving clinical outcomes, optimizing costs, and connecting more efficiently with the customer — healthcare’s triple aim.
With our deep understanding of this growing sector, Leerink Partners provides strategic guidance, insights and capital to power Digital Health and Health Tech innovators as they seek to leverage the opportunities driven by increased consumer demand.
Recent transactions
Our Digital Health & HealthTech team
Our leading team of professionals leverages their knowledge, experience and singular healthcare focus to help our clients define and achieve their strategic, capital markets and investment objectives in the healthcare industry.
- Research
- Management
Michael Cherny is a Senior Managing Director and Senior Research Analyst at Leerink Partners covering Healthcare Technology and Distribution.
Prior to joining the Firm in 2023, Michael’s most recent role was at Bank of America Merrill Lynch where he was Managing Director / Healthcare Technology & Distribution Analyst. Prior to Bank of America Merrill Lynch, Michael was the Healthcare Technology & Distribution Analyst at UBS Securities and held roles at Evercore ISI and Deutsche Bank within the healthcare and technology sector.
He earned his bachelor’s degree in business administration from Emory University.
Caroline Cameron is the Chief Operating Officer of Investment Banking at Leerink Partners.
Prior to joining the Firm in 2024, Caroline was the Chief Operating Officer at Keefe, Bruyette & Woods (KBW, A Stifel Company). Prior to her time at Keefe, Bruyette & Woods, she worked in investment banking at Edgeview Partners (acquired by Piper Jaffrey), and as a research analyst at Fox-Pitt, Kelton and Macquarie Capital.
She earned a B.A. in Psychology and Economics from Hamilton College where she graduated Phi Beta Kappa.
Jim Kelly is a Senior Managing Director, Director of Research at Leerink Partners. Mr. Kelly is responsible for product management, analyst development and equity strategy.
Prior to joining Leerink Partners in 2015, Mr. Kelly worked at Credit Suisse, where he served in research management as an Associate Director of Equity Research in New York and was responsible for leading key, strategic initiatives in research product and process development. Prior to his ADOR role at Credit Suisse, Mr. Kelly spent 13 years in Equity Research covering the US Pharmaceuticals industry for Lehman Brothers, Goldman Sachs and Credit Suisse First Boston.
Mr. Kelly received his M.B.A. from Columbia Business School and earned his B.S. in Mechanical Engineering from Lehigh University. Mr. Kelly also serves on the board of the Lehigh Business School Dean’s Advisory Council.
Christian Clark is the Associate Director of Research at Leerink Partners. He is responsible for product management, equity strategy and for leading key strategic initiatives. Prior to this role, Christian was the firm’s Business Manager of the Healthcare Services & Technology and MD&D investment banking team where he was responsible for managing the group’s overall operations including strategic planning, financial and business reporting and analytics, people management and recruiting.
Prior to Leerink Partners, Mr. Clark worked at Credit Suisse and held a variety of business and strategy positions within the Equities division. Prior to this role, he was a Fixed Income client consultant at Bloomberg LP.
Mr. Clark earned his B.S. in Finance (Summa Cum Laude) from Pennsylvania State University.
Featured Insights
Tariff Risks Underappreciated: Key Considerations and What Companies are Saying
Tecfidera® Was a Bargain, Price Increases and All
